Biomerica (BMRA) EBITDA Margin (2010 - 2026)
Biomerica's (BMRA) quarterly EBITDA Margin came in at 132.93% in Q1 2026, down 2891.0% year-on-year from 4.76% in Q1 2025, and down 21.76% quarter-over-quarter from 109.17% in Q4 2025.
Biomerica (BMRA) EBITDA Margin (2010 - 2026) Analysis & Trends
Biomerica has disclosed EBITDA Margin across 17 years of filings, most recently posting 132.93% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 132.93%, down 2891.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 96.28% (down 1067.0% YoY), and the FY2025 annual result was 93.69%, up 1656.0% from the prior year.
- EBITDA Margin came in at 132.93% for Q1 2026 at Biomerica, down from 109.17% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 0.29% in Q3 2025 to a low of 205.07% in Q2 2025.
- The 5-year median for EBITDA Margin is 109.17% (2025), against an average of 102.59%.
- Across the five-year window, EBITDA Margin surged 12888 bps in 2022 and sank 14847 bps in 2023, its largest moves.
- Biomerica's EBITDA Margin stood at 110.32% in 2022, then climbed by 13 bps to 96.17% in 2023, then jumped by 39 bps to 58.31% in 2024, then plunged by 87 bps to 109.17% in 2025, then fell by 22 bps to 132.93% in 2026.
- The last three EBITDA Margin figures came in at 132.93% (Q1 2026), 109.17% (Q4 2025), and 0.29% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 | -132.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -132.93% |
| Nov 30, 2025 | -109.17% |
| Aug 31, 2025 | 0.29% |
| May 31, 2025 | -205.07% |
| Feb 28, 2025 | -104.02% |
| Nov 30, 2024 | -58.31% |
| Aug 31, 2024 | -73.16% |
| May 31, 2024 | -127.33% |
| Feb 29, 2024 | -188.40% |
| Nov 30, 2023 | -96.17% |
| Aug 31, 2023 | -65.73% |
| May 31, 2023 | -161.64% |
| Feb 28, 2023 | -149.86% |
| Nov 30, 2022 | -110.32% |
| Aug 31, 2022 | -127.37% |
| May 31, 2022 | -33.42% |
| Feb 28, 2022 | -1.39% |
| Nov 30, 2021 | -24.32% |
| Aug 31, 2021 | -122.68% |
| May 31, 2021 | -162.30% |